Initially, I had every intention to write a cookie-cutter assessment of intriguing biotech stocks; that is, I wanted to say that enterprises within this specialized healthcare field will always be relevant as humans leverage advanced innovations to address vexing conditions and diseases. That remains true. However, the latest political paradigm shift warrants a different discussion.
0 Comments
Despite unfavorable market conditions for the past year, consumer spending has not slowed. Consumer spending has exploded over the pandemic, growing from $484.5 million in 2021 to $535.7 million in 2023, representing a 10.5% increase over two years. Despite positive growth trends, Nike (NYSE:NKE) faced difficulties recently. Nike’s stock price slipped 24% in the past
0 Comments
Selling stocks just because of the negative momentum riding behind them is not typically a good idea. However, for the firms that have lost their way, with questionable (and perhaps deteriorating) long-term growth narratives, decaying fundamentals, or other uncertainties that could weigh heavily on one’s longer-term (think three to five years or more) investment thesis,
0 Comments
It’s not just big tech stocks that have experienced a pullback lately. Many other highly-followed stocks have as well, including some of blue-chip stocks. Blue-chips may be known for their consistency and perceived lower levels of risks, but many investors have in recent months become fairly cautious about many names in this category. In some
0 Comments